Intercept Pharma Brings On Immunomedics GC As Top Atty

Law360 (January 12, 2021, 4:10 PM EST) -- The top lawyer at the drug development firm Immunomedics has left for a general counsel spot at liver disease-focused Intercept Pharmaceuticals Inc. following Immunomedics' $21 billion sale to Gilead Sciences last year.

Intercept announced on Monday it was hiring Jared M. Freedberg, who spent two years as general counsel at Immunomedics, a New Jersey-based company that is developing treatments for multiple types of cancers. In addition to serving as the company's new top lawyer, Freedberg will double as its secretary.

"I am thrilled to be joining Intercept because of the company's unique focus on helping patients with challenging liver diseases that...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!